The data appeared to slam the door on the idea that the advent of GLP-1 drugs would eliminate demand for drugs specifically ...

Cantor Fitzgerald analysts maintained an Overweight rating on Teradyne stock (NASDAQ:TER) with a steady price target of $160.00. The $20.2 billion semiconductor testing equipment maker, currently ...